Amgen (AMGN)

SG&A Expenses

$7.00B

TTM · Period ending: · USD

AMGN logo

AMGN SG&A Expenses

Latest reported$7.00B
AMGN TTM SG&A Expenses ($0.00 → $7.00B)
High-resolution chart · PNG

AMGN sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amgen SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
874,800,000
853,400,000
826,900,000
782,000,000
739,000,000
691,100,000
654,300,000
596,100,000
570,400,000
535,200,000
515,400,000
495,700,000
480,900,000
484,400,000
483,800,000
486,400,000
485,500,000
491,200,000
485,500,000
470,300,000
458,500,000
431,700,000
418,300,000
399,200,000
386,300,000
371,700,000
359,800,000
429,800,000
478,500,000
534,600,000
583,700,000
471,000,000
458,900,000
429,600,000
397,400,000
441,300,000
393,100,000
476,600,000
443,700,000
450,600,000
415,600,000
257,200,000
228,400,000
171,900,000
152,400,000
134,600,000
97,900,000
51,600,000
23,900,000
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.